MedTrace Logo

Genotoxicity Assessment for Patients Undergoing Radiation Treatment

NCT00167427 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 47

Last updated 2024-03-07

No results posted yet for this study

Summary

The purpose of the research study is to evaluate an automated, laser-based technique for measuring DNA damage caused by radiation during cancer treatment in immature red blood cells.

Conditions

  • Neoplasms

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • Yuhchyau Chen

    lead OTHER

Principal Investigators

  • Yuhchyau Chen, MD, Ph.D · Universtiy of Rochester, Dept of Radiation Oncology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2024-02-23
Completion
2024-02-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00167427 on ClinicalTrials.gov